U.S. Markets closed

Company News for Dec 10, 2019

Zacks Equity Research
  • Shares of ArQule, Inc. ARQL jumped 103.9% after Merck & Co., Inc. said it would buy the company in a deal worth $2.7 billion
  •  Shares of Synthorx, Inc. THOR soared 170.5% after Sanofi SA said that it will acquire the company for an aggregated equity value of around $2.5 billion
  • Shares of Canopy Growth Corporation CGC rose 14.2% after the company announced David Klein as the new CEO
  • Shares of Fate Therapeutics, Inc. FATE rose 41.3% after the company announced positive preliminary data from its FT596 study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Synthorx, Inc. (THOR) : Free Stock Analysis Report
Fate Therapeutics, Inc. (FATE) : Free Stock Analysis Report
ArQule, Inc. (ARQL) : Free Stock Analysis Report
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research